CompaniesBiologics Process Development

Biologics Process Development

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

20,000

By Phase

PHASE3: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
Today
NCT06282315
Hover over trial bars to see details

Recent Trials

NCT06282315Collaborator
Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness
PHASE3Recruiting
20,000 participants
Started: Sep 1, 2025 · Completed: Feb 28, 2027
Related Companies
Viropro
acquired